Already have an account? Sign in.
Evercore ISI Initiates Street-High Price Target for CoreWeave
CoreWeave received an Outperform rating and a $175 price target from Evercore ISI.
CoreWeave received an Outperform rating and a $175 price target from Evercore ISI.
FDA approves mFlusiva, Moderna’s first mRNA flu vaccine for adults 50+. Available soon for the 2026 season with strong trial results.
Newly independent Honeywell Aerospace lowers 2026 sales growth to 4-5% and weakens EPS guidance as supply constraints limit aftermarket sales.
SOUN stock surged after posting record $61.9M Q2 revenue (up 45%), stronger margins, and raising full-year 2026 outlook to $230–$260 million.